mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2026-1-7-12mrj-1899Research ArticleЛЕКЦИИLECTURESЭпштейна–Барр вирусная инфекция и ревматические заболеванияEpstein–Barr virus infection and rheumatic diseaseshttps://orcid.org/0000-0002-5264-337XБарановаМ. М.BaranovaM. M.

Марина Михайловна Баранова

Россия, 115522, Москва, Каширское шоссе, 34А

Marina Mikhailovna Baranova

34A, Kashirskoe Shosse, Moscow 115522, Russia 

baranovamarina103@gmail.comhttps://orcid.org/0000-0003-4327-6720МуравьеваН. В.MuravyevaN. V.

Россия, 115522, Москва, Каширское шоссе, 34А

 34A, Kashirskoe Shosse, Moscow 115522, Russia 

https://orcid.org/0000-0001-7091-2054БеловБ. С.BelovB. S.

Россия, 115522, Москва, Каширское шоссе, 34А 

34A, Kashirskoe Shosse, Moscow 115522, Russia

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation202619022026201712Copyright © Баранова М.М., Муравьева Н.В., Белов Б.С., 20262026Баранова М.М., Муравьева Н.В., Белов Б.С.Baranova M.M., Muravyeva N.V., Belov B.S.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/1899

Вирус Эпштейна–Барр – широко распространенный герпесвирус 4-го типа, которым инфицировано свыше 90% населения планеты. Его роль в развитии ревматических заболеваний активно изучается. В статье представлен анализ ключевых аспектов этой взаимосвязи, основанный на современных исследованиях.

Epstein–Barr virus is a highly prevalent human herpesvirus type 4, infecting more than 90% of the world’s population. Its role in the development of rheumatic diseases is actively being investigated. This article presents an analysis of key  aspects of this association based on current research.

Эпштейна–Барр вируссистемная красная волчанкаревматоидный артритболезнь ШегренаEpstein–Barr virussystemic lupus erythematosusrheumatoid arthritisSjögren’s diseaseСтатья подготовлена в рамках научно-исследовательской работы, № государственного задания РК 125020301268-4The article was prepared within the framework of a research project under State Assignment № RK 125020301268-4.Referenceshttps://library.mededtech.ru/rest/documents/Inf_mononuclpdf23/https://library.mededtech.ru/rest/documents/Inf_mononuclpdf23/Robinson WH, Younis S, Love ZZ, et al. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024 Nov; 20(11):729-740. doi: 10.1038/s41584-024-01167-9.Robinson WH, Younis S, Love ZZ, et al. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024 Nov; 20(11):729-740. doi: 10.1038/s41584-024-01167-9.Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021 Jan 7:11:587380. doi: 10.3389/fimmu.2020.587380.Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 2021 Jan 7:11:587380. doi: 10.3389/fimmu.2020.587380.Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J. 2008 Jan;10(1):8-12.Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J. 2008 Jan;10(1):8-12.Jog NR, James JA. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Front Immunol. 2021 Feb 3: 11:623944. doi: 10.3389/fimmu.2020.623944.Jog NR, James JA. Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus. Front Immunol. 2021 Feb 3: 11:623944. doi: 10.3389/fimmu.2020.623944.Minamitani T, Yasui T, Ma Y, et al. Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A. 2015 Sep 15;112(37): 11612-7. doi: 10.1073/pnas.1514484112.Minamitani T, Yasui T, Ma Y, et al. Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proc Natl Acad Sci U S A. 2015 Sep 15;112(37): 11612-7. doi: 10.1073/pnas.1514484112.Wang H, Nicholas MW, Conway KL, et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol. 2006 Sep 1;177(5): 2793-802. doi: 10.4049/jimmunol.177.5.2793.Wang H, Nicholas MW, Conway KL, et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol. 2006 Sep 1;177(5): 2793-802. doi: 10.4049/jimmunol.177.5.2793.Croia C, Serafini B, Bombardieri M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. 2013 Sep 1;72(9):1559-68. doi: 10.1136/annrheumdis-2012-202352.Croia C, Serafini B, Bombardieri M, et al. Epstein-Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis. 2013 Sep 1;72(9):1559-68. doi: 10.1136/annrheumdis-2012-202352.Takei M, Kitamura N, Nagasawa Y, et al. Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein-Barr Virus. Viruses. 2022 Aug 27;14(9):1900. doi: 10.3390/v14091900.Takei M, Kitamura N, Nagasawa Y, et al. Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein-Barr Virus. Viruses. 2022 Aug 27;14(9):1900. doi: 10.3390/v14091900.Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis. 2012: 2012:189096. doi: 10.1155/2012/189096.Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis. Autoimmune Dis. 2012: 2012:189096. doi: 10.1155/2012/189096.Draborg AH, Jacobsen S, Westergaard M, et al. Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients. Lupus Sci Med. 2014 Apr 1; 1(1):e000015. doi: 10.1136/lupus-2014-000015.Draborg AH, Jacobsen S, Westergaard M, et al. Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients. Lupus Sci Med. 2014 Apr 1; 1(1):e000015. doi: 10.1136/lupus-2014-000015.Takei M, Ishiwata T, Mitamura K, et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol. 2001 Apr; 13(4):559-65. doi: 10.1093/intimm/13.4.559.Takei M, Ishiwata T, Mitamura K, et al. Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol. 2001 Apr; 13(4):559-65. doi: 10.1093/intimm/13.4.559.Горячев ДВ, Егорова ОН, Балабанова РМ. Системная красная волчанка и вирусные инфекции. Научно-практическая ревматология. 2000;(3):45-54.Goryachev DV, Egorova ON, Balabanova RM. Systemic lupus erythematosus and viral infections. Nauchno-prakticheskaya revmatologia. 2000;(3):45-54. (In Russ.).Arbuckle MR, Reichlin M, Harley JB, et al. Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol. 1999 Nov; 50(5):447-55. doi: 10.1046/j.1365-3083. 1999.00640.x.Arbuckle MR, Reichlin M, Harley JB, et al. Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus. Scand J Immunol. 1999 Nov; 50(5):447-55. doi: 10.1046/j.1365-3083. 1999.00640.x.James JA, Harley JB, Scofield RH. Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol. 2006 Sep; 18(5):462-7. doi: 10.1097/01.bor.0000240355.37927.94.James JA, Harley JB, Scofield RH. Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol. 2006 Sep; 18(5):462-7. doi: 10.1097/01.bor.0000240355.37927.94.Poole BD, Scofield RH, Harley JB, et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006 Feb;39(1):63-70. doi: 10.1080/08916930500484849.Poole BD, Scofield RH, Harley JB, et al. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity. 2006 Feb;39(1):63-70. doi: 10.1080/08916930500484849.McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005 Jan;11(1):85-9. doi: 10.1038/nm1167.McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med. 2005 Jan;11(1):85-9. doi: 10.1038/nm1167.Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993 May;23(5):1146-52. doi: 10.1002/eji.1830230525.Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol. 1993 May;23(5):1146-52. doi: 10.1002/eji.1830230525.Sundar K, Jacques S, Gottlieb P, et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and antiSm antibodies. J Autoimmun. 2004 Sep;23(2): 127-40. doi: 10.1016/j.jaut.2004.06.001.Sundar K, Jacques S, Gottlieb P, et al. Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and antiSm antibodies. J Autoimmun. 2004 Sep;23(2): 127-40. doi: 10.1016/j.jaut.2004.06.001.Yadav P, Tran H, Ebegbe R, et al. Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One. 2011 Jan 4;6(1):e14488. doi: 10.1371/journal.pone.0014488.Yadav P, Tran H, Ebegbe R, et al. Antibodies elicited in response to EBNA-1 may cross-react with dsDNA. PLoS One. 2011 Jan 4;6(1):e14488. doi: 10.1371/journal.pone.0014488.Csorba K, Schirmbeck LA, Tuncer E, et al. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site. Front Immunol. 2019 Nov 7:10: 2619. doi: 10.3389/fimmu.2019.02619.Csorba K, Schirmbeck LA, Tuncer E, et al. Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site. Front Immunol. 2019 Nov 7:10: 2619. doi: 10.3389/fimmu.2019.02619.Incaprera M, Rindi L, Bazzichi A, et al. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol. 1998 May-Jun;16(3): 289-94.Incaprera M, Rindi L, Bazzichi A, et al. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol. 1998 May-Jun;16(3): 289-94.Baboonian C, Venables PJ, Williams DG, et al. Cross reaction of antibodies to a glycine/alanine repeat sequence of EpsteinBarr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis. 1991 Nov;50(11):772-5. doi: 10.1136/ard.50.11.772.Baboonian C, Venables PJ, Williams DG, et al. Cross reaction of antibodies to a glycine/alanine repeat sequence of EpsteinBarr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann Rheum Dis. 1991 Nov;50(11):772-5. doi: 10.1136/ard.50.11.772.Davies JM, Mackay IR, Rowley MJ. Rheumatoid arthritis sera react with a phagedisplayed peptide selected by a monoclonal antibody to type II collagen that has homology to EBNA-1. Autoimmunity. 1999;30(1): 53-9. doi: 10.3109/08916939908994760.Davies JM, Mackay IR, Rowley MJ. Rheumatoid arthritis sera react with a phagedisplayed peptide selected by a monoclonal antibody to type II collagen that has homology to EBNA-1. Autoimmunity. 1999;30(1): 53-9. doi: 10.3109/08916939908994760.Trier NH, Holm BE, Heiden J, et al. Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis. Sci Rep. 2018 Feb 27;8(1):3684. doi: 10.1038/s41598-018-22058-6.Trier NH, Holm BE, Heiden J, et al. Antibodies to a strain-specific citrullinated Epstein-Barr virus peptide diagnoses rheumatoid arthritis. Sci Rep. 2018 Feb 27;8(1):3684. doi: 10.1038/s41598-018-22058-6.Illescas-Montes R, Corona-Castro CC, Melguizo-Rodriguez L, et al. Infectious processes and systemic lupus erythematosus. Immunology. 2019 Nov;158(3):153-160. doi: 10.1111/imm.13103.Illescas-Montes R, Corona-Castro CC, Melguizo-Rodriguez L, et al. Infectious processes and systemic lupus erythematosus. Immunology. 2019 Nov;158(3):153-160. doi: 10.1111/imm.13103.Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol. 2009 Apr;9(4):246-58. doi: 10.1038/nri2527.Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat Rev Immunol. 2009 Apr;9(4):246-58. doi: 10.1038/nri2527.Martin HJ, Lee JM, Walls D, et al. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol. 2007 Sep;81(18):9748-58. doi: 10.1128/JVI.01122-07.Martin HJ, Lee JM, Walls D, et al. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol. 2007 Sep;81(18):9748-58. doi: 10.1128/JVI.01122-07.Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011 Jan 5; 2(1):1. doi: 10.1186/2042-4280-2-1.Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011 Jan 5; 2(1):1. doi: 10.1186/2042-4280-2-1.Valente R.M., Ehlers E., Xu D., Ahmad H., Steadman A., Blasnitz L. et al. Toll-Like receptor 7 stimulates the expression of Epstein–Barr virus latent membrane protein 1. PLoS One. 2012;7(8):e43317. doi: 10.1371/journal.pone.0043317.Valente R.M., Ehlers E., Xu D., Ahmad H., Steadman A., Blasnitz L. et al. Toll-Like receptor 7 stimulates the expression of Epstein–Barr virus latent membrane protein 1. PLoS One. 2012;7(8):e43317. doi: 10.1371/journal.pone.0043317.Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019 Feb;19(1):23-36. doi: 10.1007/s10238-018-0535-0.Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019 Feb;19(1):23-36. doi: 10.1007/s10238-018-0535-0.Jog NR, Young KA, Munroe ME, et al. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. 2019 Sep;78(9):1235-1241. doi: 10.1136/annrheumdis-2019-215361.Jog NR, Young KA, Munroe ME, et al. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. 2019 Sep;78(9):1235-1241. doi: 10.1136/annrheumdis-2019-215361.Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis. 2006;64(1-2):45-50.Harley JB, James JA. Epstein-Barr virus infection induces lupus autoimmunity. Bull NYU Hosp Jt Dis. 2006;64(1-2):45-50.Moon UY, Park SJ, Oh ST, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther. 2004;6(4):R295-302. doi: 10.1186/ar1181.Moon UY, Park SJ, Oh ST, et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther. 2004;6(4):R295-302. doi: 10.1186/ar1181.Balandraud N, Meynard JB, Auger I, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 2003 May;48(5):1223-8. doi: 10.1002/art.10933.Balandraud N, Meynard JB, Auger I, et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthritis Rheum. 2003 May;48(5):1223-8. doi: 10.1002/art.10933.Takeda T, Mizugaki Y, Matsubara L, et al. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2000 Jun;43(6):1218-25. doi: 10.1002/1529-0131(200006)43:6<1218:AID-ANR4>3.0.CO;2-2.Takeda T, Mizugaki Y, Matsubara L, et al. Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2000 Jun;43(6):1218-25. doi: 10.1002/1529-0131(200006)43:6<1218:AID-ANR4>3.0.CO;2-2.Blaschke S, Schwarz G, Moneke D, et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol. 2000 Apr; 27(4):866-73.Blaschke S, Schwarz G, Moneke D, et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol. 2000 Apr; 27(4):866-73.Fechtner S, Berens H, Bemis E, et al. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles. Arthritis Rheumatol. 2022 Apr; 74(4):597-603. doi: 10.1002/art.41994.Fechtner S, Berens H, Bemis E, et al. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles. Arthritis Rheumatol. 2022 Apr; 74(4):597-603. doi: 10.1002/art.41994.Banko A, Miljanovic D, Lazarevic I, et al. New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis. Viruses. 2022 Jan 10; 14(1):115. doi: 10.3390/v14010115.Banko A, Miljanovic D, Lazarevic I, et al. New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis. Viruses. 2022 Jan 10; 14(1):115. doi: 10.3390/v14010115.Whittingham S, McNeilage LJ, Mackay IR. Epstein-Barr virus as an etiological agent in primary Sjögren's syndrome. Med Hypotheses. 1987 Apr;22(4):373-86. doi: 10.1016/0306-9877(87)90033-8.Whittingham S, McNeilage LJ, Mackay IR. Epstein-Barr virus as an etiological agent in primary Sjögren's syndrome. Med Hypotheses. 1987 Apr;22(4):373-86. doi: 10.1016/0306-9877(87)90033-8.Tsubota K, Fujishima H, Toda I, et al. Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjögren's syndrome patients. Acta Ophthalmol Scand. 1995 Oct; 73(5):425-30. doi: 10.1111/j.1600-0420.1995.tb00302.x.Tsubota K, Fujishima H, Toda I, et al. Increased levels of Epstein-Barr virus DNA in lacrimal glands of Sjögren's syndrome patients. Acta Ophthalmol Scand. 1995 Oct; 73(5):425-30. doi: 10.1111/j.1600-0420.1995.tb00302.x.Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol. 1986 Nov 15;137(10):3162-8.Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol. 1986 Nov 15;137(10):3162-8.Pasoto SG, Natalino RR, Chakkour HP, et al. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement? Rheumatol Int. 2013 May;33(5):1149-57. doi: 10.1007/s00296-012-2504-3.Pasoto SG, Natalino RR, Chakkour HP, et al. EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement? Rheumatol Int. 2013 May;33(5):1149-57. doi: 10.1007/s00296-012-2504-3.Croia C, Astorri E, Murray-Brown W, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjö-gren's syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2545-57. doi: 10.1002/art.38726.Croia C, Astorri E, Murray-Brown W, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjö-gren's syndrome. Arthritis Rheumatol. 2014 Sep;66(9):2545-57. doi: 10.1002/art.38726.Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005 Jun 1;174(11):6599-607. doi: 10.4049/jimmunol.174.11.6599.Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005 Jun 1;174(11):6599-607. doi: 10.4049/jimmunol.174.11.6599.Chen CJ, Lin KH, Lin SC, et al. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol. 2005 Jan; 32(1):44-7.Chen CJ, Lin KH, Lin SC, et al. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies. J Rheumatol. 2005 Jan; 32(1):44-7.Gao S, Yu Z, Ma X, et al. Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study. Lancet Child Adolesc Health. 2024 Oct;8(10):762-772. doi: 10.1016/S2352-4642(24)00172-X.Gao S, Yu Z, Ma X, et al. Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study. Lancet Child Adolesc Health. 2024 Oct;8(10):762-772. doi: 10.1016/S2352-4642(24)00172-X.Nakamura J, Yanagida M, Saito K, et al. Epstein-Barr virus encephalitis in a patient with rheumatoid arthritis. Mod Rheumatol Case Rep. 2022 Jun 24;6(2):160-162. doi: 10.1093/mrcr/rxab045.Nakamura J, Yanagida M, Saito K, et al. Epstein-Barr virus encephalitis in a patient with rheumatoid arthritis. Mod Rheumatol Case Rep. 2022 Jun 24;6(2):160-162. doi: 10.1093/mrcr/rxab045.Yamashita H, Shimizu A, Tsuchiya H, et al. Chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis exacerbation in a patient with systemic lupus erythematosus. Lupus. 2014 Jul;23(8):833-6. doi: 10.1177/0961203314527367.Yamashita H, Shimizu A, Tsuchiya H, et al. Chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis exacerbation in a patient with systemic lupus erythematosus. Lupus. 2014 Jul;23(8):833-6. doi: 10.1177/0961203314527367.Haramura T, Haraguchi M, Irie J, et al. Case of plasmablastic lymphoma of the sigmoid colon and literature review. World J Gastroenterol. 2015 Jun 28;21(24):7598-603. doi: 10.3748/wjg.v21.i24.7598.Haramura T, Haraguchi M, Irie J, et al. Case of plasmablastic lymphoma of the sigmoid colon and literature review. World J Gastroenterol. 2015 Jun 28;21(24):7598-603. doi: 10.3748/wjg.v21.i24.7598.Егорова ОН, Балабанова РМ, Сажина ЕГ. Системная красная волчанка и оппортунистические инфекции: распространенность, клинические особенности. Современная ревматология. 2008;2(4):27-33. doi: 10.14412/1996-7012-2008-503.Egorova ON, Balabanova RM, Sazhina EG. Systemic lupus erythematosus and opportunistic infections: prevalence, clinical features. Modern Rheumatology Journal. 2008; 2(4):27-33. (In Russ.). doi: 10.14412/1996-7012-2008-503.Tiwari V, Bergman MJ. Viral Arthritis. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.Tiwari V, Bergman MJ. Viral Arthritis. In: StatPearls. Treasure Island: StatPearls Publishing; 2025.Kim TH, Lee JH, Kim YC, Lee SE. Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus. J Cutan Pathol. 2015 Mar;42(3):229-231. doi: 10.1111/cup.12425.Kim TH, Lee JH, Kim YC, Lee SE. Hydroa vacciniforme-like lymphoma misdiagnosed as cutaneous lupus erythematosus. J Cutan Pathol. 2015 Mar;42(3):229-231. doi: 10.1111/cup.12425.Plaza JA, Sangueza M. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma. Am J Dermatopathol. 2015 Jan; 37(1):20-5. doi: 10.1097/DAD.0000000000000158.Plaza JA, Sangueza M. Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma. Am J Dermatopathol. 2015 Jan; 37(1):20-5. doi: 10.1097/DAD.0000000000000158.Бзарова Т, Алексеева Е, Акулова С. Случай Эпштейн-Барр вирусной инфекции, протекавшей под маской системного варианта ювенильного ревматоидного артрита. Вопросы современной педиатрии. 2007;6(3):101-106.Bzarova T, Alekseeva E, Akulova S. A case of Epstein-Barr virus infection that presented as a systemic variant of juvenile rheumatoid arthritis. Voprosy sovremennoi pediatrii. 2007;6(3):101-106. (In Russ.).

The authors declare that there are no conflicts of interest present.